These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 3199686)

  • 1. Angiotensin receptor: properties and relevance to the development of antagonists.
    Soffer RL; Kiron MA; Rosenberg E; Bandyopadhyay S
    Kidney Int Suppl; 1988 Oct; 26():S69-72. PubMed ID: 3199686
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence for agonist-induced interaction of angiotensin receptor with a guanine nucleotide-binding protein in bovine adrenal zona glomerulosa.
    De Léan A; Ong H; Gutkowska J; Schiller PW; McNicoll N
    Mol Pharmacol; 1984 Nov; 26(3):498-508. PubMed ID: 6092899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Searching for a long acting angiotensin II antagonist].
    Escher E
    Union Med Can; 1980 Oct; 109(10):1477-9. PubMed ID: 7466971
    [No Abstract]   [Full Text] [Related]  

  • 4. Angiotensin II receptors in rabbit vascular grafts.
    Hausner EA; Turner MJ; Trzaskos JM; Herblin WF
    Biochem Biophys Res Commun; 1993 Jan; 190(1):27-32. PubMed ID: 8422252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Angiotensin receptors in the rat myocardium during pre- and postnatal development].
    Sechi LA; Sechi G; De Carli S; Griffin CA; Schambelan M; Bartoli E
    Cardiologia; 1993 Jul; 38(7):471-6. PubMed ID: 8221742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The contribution of the N-terminal region of angiotensin II antagonists to receptor binding.
    Ganter RC; Goghari MH; Moore GJ
    Proc West Pharmacol Soc; 1987; 30():113-6. PubMed ID: 3628261
    [No Abstract]   [Full Text] [Related]  

  • 7. Properties of [3H]LF 7-0156, a new nonpeptide antagonist radioligand for the type 1 angiotensin II receptor.
    Nouet S; Dodey P; Renaut P; Marie J; Pruneau D; Larguier R; Lombard C; Bonnafous JC
    Mol Pharmacol; 1994 Oct; 46(4):693-701. PubMed ID: 7969048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Angiotensin II receptor antagonists. Clinically significant differences].
    Ibsen H; Rasmussen S
    Ugeskr Laeger; 1999 Sep; 161(38):5332-6. PubMed ID: 10536525
    [No Abstract]   [Full Text] [Related]  

  • 9. Angiotensin II receptor inhibition. A new therapeutic principle.
    Messerli FH; Weber MA; Brunner HR
    Arch Intern Med; 1996 Sep; 156(17):1957-65. PubMed ID: 8823149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The development of nonpeptide angiotensin II receptor antagonists: a success story.
    Höltje HD; Jessen G; Höltje M
    Pharmazie; 1997 Feb; 52(2):83-6. PubMed ID: 9122281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Left ventricular hypertrophy regression in arterial hypertension. The efficacy of the angiotensin II type 1 receptor antagonists].
    González-Juanatey JR; Vallés Belsué F
    Med Clin (Barc); 2000; 114 Suppl 1():39-42. PubMed ID: 10812574
    [No Abstract]   [Full Text] [Related]  

  • 12. [The role of G-regulatory proteins in the intracellular mechanism of cardiac angiotensin-II receptors].
    Sechi LA; Sechi G; De Carli S; Griffin CA; Schambelan M; Bartoli E
    Cardiologia; 1993 Aug; 38(8):519-23. PubMed ID: 8313407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II receptors and angiotensin II receptor antagonists.
    Timmermans PB; Wong PC; Chiu AT; Herblin WF; Benfield P; Carini DJ; Lee RJ; Wexler RR; Saye JA; Smith RD
    Pharmacol Rev; 1993 Jun; 45(2):205-51. PubMed ID: 8372104
    [No Abstract]   [Full Text] [Related]  

  • 14. Angiotensin converting enzyme inhibitors as potential cognitive enhancing agents.
    Domeney AM
    J Psychiatry Neurosci; 1994 Jan; 19(1):46-50. PubMed ID: 8148365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [On angiotensin II receptor antagonists in the treatment of hypertension].
    Ibsen H
    Ugeskr Laeger; 1999 Sep; 161(38):5287. PubMed ID: 10536511
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacokinetic and pharmacodynamic aspects of angiotensin II antagonists. Focus on arterial hypertension].
    da Silva PM
    Rev Port Cardiol; 1998 Jun; 17(6):545-55. PubMed ID: 9677832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thoughts and studies on purification of the angiotensin II receptor.
    Soffer RL
    J Hypertens Suppl; 1986 Oct; 4(4):S17-20. PubMed ID: 3534180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the mechanisms of action of two classes of angiotensin antagonists at smooth muscle receptors.
    Moore GJ; Matsoukas JM; Scanlon MN; Franklin KJ; Goghari MH
    Proc West Pharmacol Soc; 1984; 27():377-83. PubMed ID: 6093134
    [No Abstract]   [Full Text] [Related]  

  • 19. Tonic suppression of spontaneous baroreceptor reflex by endogenous angiotensins via AT(2) subtype receptors at nucleus reticularis ventrolateralis in the rat.
    Lin K; Chan SH; Chan JY
    Synapse; 2001 Apr; 40(1):85-94. PubMed ID: 11170225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of angiotensin-II-antagonists in hypertension].
    Birkenhäger WH; de Leeuw PW
    Ned Tijdschr Geneeskd; 2000 Jul; 144(29):1397-402. PubMed ID: 10923148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.